NCT02540174 2026-03-13
ALTAKRA-1405
Centre Oscar Lambret
Phase NA Completed
Clinical Trials
3 trialsNCT05681039 2026-03-02
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04890834 2026-02-19
Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers
M.D. Anderson Cancer Center
Phase NA Active not recruiting